Effects of Body Awareness Therapy on Physical and Psychosocial Outcomes in Adults With Asthma

ConditionAsthma
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorRecep Tayyip Erdogan University

About this trial

This study aims to investigate the effects of Body Awareness Therapy on physical and psychosocial outcomes in adults with asthma. Asthma is a chronic respiratory condition that can affect breathing, physical activity, and emotional well-being. In addition to medical treatment, non-pharmacological approaches that support body awareness and breathing may help individuals manage their symptoms more effectively.

Participants in this study will be randomly assigned to either a Body Awareness Therapy group or a control group receiving standard care. The Body Awareness Therapy program includes guided exercises focusing on posture, breathing, movement, and awareness of bodily sensations. The program will be delivered over several weeks by a trained physiotherapist.

The main outcomes of the study include physical function, respiratory symptoms, quality of life, psychological well-being, and body awareness levels. The results of this study are expected to provide evidence on whether Body Awareness Therapy can be an effective supportive approach in asthma management and rehabilitation.

Eligibility criteria

Qualifiers

Adults aged between 18 and 65 years.

Clinically diagnosed asthma confirmed by a physician.

Stable asthma condition (no acute exacerbation in the last 4 weeks).

Receiving regular medical treatment for asthma.

Disqualifiers

Diagnosis of chronic respiratory diseases other than asthma (e.g., COPD, bronchiectasis).

Acute asthma exacerbation within the last 4 weeks.

Severe cardiovascular, neurological, or musculoskeletal conditions that may limit participation in physical activity.

Current participation in another structured exercise or rehabilitation program.

Trial design

Treatments tested in this trial

  • Body Awareness Therapy
  • Standart Care

Treatment groups

67 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Recep Tayyip Erdogan University

Lead sponsor

İstanbul Yeni Yüzyıl Üniversitesi

Collaborator